Parenteral low dose type 1 interferons for bladder cancer

Details Parenteral low dose type 1 interferons for bladder cancer Parenteral low dose type 1 interferons for bladder cancer

A - Human Necessities

61

K

A61K 38/21 (2006.01) A61K 39/04 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2648077

Novel methods and drug products for treating superficial bladder cancer (SBC) are disclosed, which involve parenteral administration of low doses of a type I interferon. The doses used are subtherapeutic for other solid tumors. Use of the novel methods and products in combination with other therapies for SBC is also described.

L'invention concerne de nouvelles méthodes et de nouveaux produits médicamenteux pour traiter le cancer superficiel de la vessie (CSV), comprenant l'administration parentérale de faibles doses d'un interféron de type I. Les doses utilisées sont infra-thérapeutiques pour d'autres tumeurs solides. L'invention concerne également l'utilisation de nouvelles méthodes et de nouveaux produits en combinaison avec d'autres thérapies pour CSV.

Affiliated with

Also associated with

Rating

Parenteral low dose type 1 interferons for bladder cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Parenteral low dose type 1 interferons for bladder cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Parenteral low dose type 1 interferons for bladder cancer will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2068078